Compound Detail
CHEMBL409
BICALUTAMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL409 |
| Name | BICALUTAMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LKJPYSCBVHEWIU-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
381
Targets
803
Activities
4
Assay Types
23
PK Parameters
20
Publications
10
Known Names
19
Indications
1
Mechanisms
Molecular Properties
430.4
MW (Da)
2.88
ALogP
5
HBA
2
HBD
107.3
PSA (Ų)
0.56
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1995 |
| Availability | Prescription |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Androgen Receptor antagonist | ANTAGONIST | Androgen receptor | ✓ | ✓ |
Indications
Carcinoma Neoplasms Breast Neoplasms Breast Neoplasms Breast Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Fallopian Tube Neoplasms Gynecomastia Ovarian Neoplasms Peritoneal Neoplasms Puberty, Precocious Salivary Gland Neoplasms Urinary Bladder Neoplasms Urinary Bladder Neoplasms
ATC Classification
L02BB03
bicalutamide
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ENDOCRINE THERAPY
Activity Summary
IC50 774 meas. best 7.6
Ki 22 meas. best 7.96
EC50 6 meas. best 7.51
Kd 1 meas. best 4.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Androgen receptor CHEMBL1871 | Ki | 7.96 | 7.1856 | 11.0 | 18 |
| Androgen receptor CHEMBL3072 | Ki | 7.85 | 6.8733 | 14.0 | 3 |
| Androgen receptor CHEMBL3072 | IC50 | 7.6 | 6.628 | 25.0 | 5 |
| Androgen receptor CHEMBL1871 | EC50 | 7.51 | 6.3817 | 31.0 | 6 |
| Liver CHEMBL613642 | IC50 | 7.31 | 7.31 | 48.9 | 1 |
| Androgen receptor CHEMBL1871 | IC50 | 7.27 | 6.5572 | 54.0 | 54 |
| LNCaP CHEMBL612518 | IC50 | 6.8 | 5.0786 | 160.0 | 14 |
| Unchecked CHEMBL612545 | IC50 | 6.8 | 6.415 | 160.0 | 2 |
| Androgen receptor CHEMBL3056 | IC50 | 6.72 | 6.1367 | 190.0 | 3 |
| HT-3 CHEMBL1075470 | IC50 | 6.14 | 6.14 | 731.3 | 1 |
| PC-3 CHEMBL390 | IC50 | 5.89 | 4.87 | 1300.0 | 6 |
| Progesterone receptor CHEMBL208 | IC50 | 5.74 | 5.74 | 1819.0 | 1 |
| CCF-STTG1 CHEMBL1075419 | IC50 | 5.31 | 5.31 | 4929.3 | 1 |
| Progesterone receptor CHEMBL3456 | IC50 | 5.25 | 5.25 | 5600.0 | 2 |
| SCC-25 CHEMBL614901 | IC50 | 5.22 | 5.22 | 6086.6 | 1 |
| MKN-45 CHEMBL614354 | IC50 | 5.16 | 5.16 | 6960.5 | 1 |
| Progesterone receptor CHEMBL2596 | Ki | 5.14 | 5.14 | 7200.0 | 1 |
| ES5 CHEMBL2366312 | IC50 | 5.07 | 5.07 | 8611.5 | 1 |
| SK-MEL3 CHEMBL614920 | IC50 | 5.0 | 5.0 | 10096.4 | 1 |
| NOS-1 CHEMBL2366141 | IC50 | 4.95 | 4.95 | 11291.8 | 1 |
| CAMA-1 CHEMBL1075416 | IC50 | 4.91 | 4.91 | 12392.6 | 1 |
| LB1047-RCC CHEMBL2366136 | IC50 | 4.91 | 4.91 | 12253.0 | 1 |
| SAS CHEMBL1075569 | IC50 | 4.88 | 4.88 | 13308.1 | 1 |
| NCI-H2228 CHEMBL1075536 | IC50 | 4.86 | 4.86 | 13753.1 | 1 |
| NCI-H187 CHEMBL2366276 | IC50 | 4.78 | 4.78 | 16661.6 | 1 |
| BFTC-905 CHEMBL1075396 | IC50 | 4.76 | 4.76 | 17485.7 | 1 |
| Albumin CHEMBL3253 | Kd | 4.75 | 4.75 | 18000.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.75 | 4.3675 | 18000.0 | 4 |
| DU-145 CHEMBL613508 | IC50 | 4.75 | 4.3214 | 18000.0 | 7 |
| G-361 CHEMBL614036 | IC50 | 4.75 | 4.75 | 17826.0 | 1 |
| SW780 CHEMBL1075595 | IC50 | 4.74 | 4.74 | 18415.0 | 1 |
| BB49-HNC CHEMBL2366295 | IC50 | 4.72 | 4.72 | 18953.2 | 1 |
| AU565 CHEMBL1075393 | IC50 | 4.71 | 4.71 | 19740.2 | 1 |
| KALS-1 CHEMBL2366155 | IC50 | 4.71 | 4.71 | 19663.5 | 1 |
| NCI-H2087 CHEMBL1075532 | IC50 | 4.68 | 4.68 | 21059.1 | 1 |
| RVH-421 CHEMBL1075567 | IC50 | 4.67 | 4.67 | 21579.5 | 1 |
| KU-19-19 CHEMBL1075483 | IC50 | 4.66 | 4.66 | 22024.2 | 1 |
| SK-CO-1 CHEMBL1075576 | IC50 | 4.66 | 4.66 | 21887.2 | 1 |
| RO82-W-1 CHEMBL1075565 | IC50 | 4.64 | 4.64 | 23131.8 | 1 |
| NB6 CHEMBL2366318 | IC50 | 4.64 | 4.64 | 22913.5 | 1 |
| CTB-1 CHEMBL2366344 | IC50 | 4.61 | 4.61 | 24553.6 | 1 |
| SW48 CHEMBL614055 | IC50 | 4.61 | 4.61 | 24654.6 | 1 |
| TCC-SUP CHEMBL615010 | IC50 | 4.61 | 4.61 | 24723.2 | 1 |
| DK-MG CHEMBL1075433 | IC50 | 4.6 | 4.6 | 24891.7 | 1 |
| ST486 CHEMBL2366293 | IC50 | 4.59 | 4.59 | 25746.4 | 1 |
| H4 CHEMBL1075452 | IC50 | 4.57 | 4.57 | 26945.8 | 1 |
| SBC-1 CHEMBL2366327 | IC50 | 4.55 | 4.55 | 28350.7 | 1 |
| HCC1954 CHEMBL1075459 | IC50 | 4.54 | 4.54 | 28752.5 | 1 |
| OAW-42 CHEMBL1075554 | IC50 | 4.54 | 4.54 | 28719.5 | 1 |
| CAS-1 CHEMBL2366100 | IC50 | 4.54 | 4.54 | 28629.4 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 46862.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 52523.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 10597.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 338278.68 | ng.hr.mL-1 | Mus musculus |
| AUC | - | - | Mus musculus |
| AUC | 216201.39 | ng.hr.mL-1 | Homo sapiens |
| CL | 0.945 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.84 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 3.75 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.32 | L/hr | Homo sapiens |
| Cmax | 3278.5 | nM | Rattus norvegicus |
| Cmax | 4630.79 | nM | Rattus norvegicus |
| Cmax | 745.85 | nM | Rattus norvegicus |
| Cmax | 110000.0 | nM | Mus musculus |
| Cmax | 1784.47 | nM | Homo sapiens |
| Cmax | 1970.0 | nM | Homo sapiens |
| Css | 8.939 | mcg/mL | Homo sapiens |
| T1/2 | 22.3 | hr | Rattus norvegicus |
| T1/2 | 23.4 | hr | Rattus norvegicus |
| T1/2 | 27.8 | hr | Rattus norvegicus |
| T1/2 | 139.2 | hr | Homo sapiens |
| Tmax | 0.5 | hr | Mus musculus |
| Tmax | 31.3 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine